Catalyst Wire Dossier Catalyst Wire Dossier

Oral recombinant human lactoferrin

recombinant human lactoferrin · Agennix
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oral recombinant human lactoferrin, covering 2008-04-10 to 2008-04-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma [Phase 2]

See pricing